The global Glaucoma Therapeutics Market, valued at USD 7.25 million in 2023, is on a robust growth trajectory and is expected to reach USD 9.62 million by 2031. This represents a compound annual growth rate (CAGR) of 3.6% over the forecast period from 2024 to 2031. Key Players Some major players in Glaucoma Therapeutics Market are Merck & Co. Inc, Allergan, Bausch & Lomb...

The Glaucoma Therapeutics  market Growth of Glaucoma Therapeutics was USD 7.67 billion in 2022 and is projected to reach USD 12.50 billion by 2030, with a compound annual growth rate (CAGR) of 6.3% during the forecast period from 2023 to 2030. Glaucoma Therapeutics is a rapidly expanding market that offers promising opportunities for growth. With an increasing...